These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1123984)
21. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. van den Born BJ; Koopmans RP; van Montfrans GA Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041 [TBL] [Abstract][Full Text] [Related]
22. [Comparative clinical study of the antihypertensive effects of urapidil versus diazoxide in patients with severe arterial hypertension]. Gasparović V; Vrhovac B; Rumboldt Z; Ivanković D Lijec Vjesn; 1986; 108(11-12):494-6. PubMed ID: 3553816 [No Abstract] [Full Text] [Related]
24. Malignant hypertension. A clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors. Gudbrandsson T Acta Med Scand Suppl; 1981; 650():1-62. PubMed ID: 6948498 [No Abstract] [Full Text] [Related]
25. Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients. Cummings YE; Dillard MG J Natl Med Assoc; 1974 Mar; 66(2):104-7 passim. PubMed ID: 4819884 [No Abstract] [Full Text] [Related]
27. The classification and treatment of essential hypertension using the renin-sodium index for vasoconstriction-volume analysis. Laragh JH Johns Hopkins Med J; 1975 Oct; 137(4):184-94. PubMed ID: 1185911 [No Abstract] [Full Text] [Related]
28. Bilateral nephrectomy: its role in management of the malignant hypertension of end-stage renal disease. Donohue JP; Bohnert WW; Shires DL; Bradley KP J Urol; 1971 Oct; 106(4):488-91. PubMed ID: 4940925 [No Abstract] [Full Text] [Related]
29. Fourteen-year survival in a case of malignant hypertension under hypotensive drug therapy. Pomerantz HZ Can Med Assoc J; 1968 Nov; 99(21):1043-7. PubMed ID: 5721944 [No Abstract] [Full Text] [Related]
30. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Khanna A; McCullough PA Rev Cardiovasc Med; 2003; 4(4):255-9. PubMed ID: 14674379 [TBL] [Abstract][Full Text] [Related]
34. Treatment of malignant hypertension. Dollery CT Mod Treat; 1966 Jan; 3(1):39-49. PubMed ID: 5904581 [No Abstract] [Full Text] [Related]
35. Malignant hypertension treated with modern antihypertensive drugs. Voudoukis IJ; Caldwell JR Pa Med; 1974 Jul; 77(7):43-8. PubMed ID: 4841134 [No Abstract] [Full Text] [Related]
36. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy]. Nast HP; Philipp T Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672 [No Abstract] [Full Text] [Related]
37. Understanding malignant hypertension. Kincaid-Smith P Aust N Z J Med; 1981; 11(Suppl 1):64-8. PubMed ID: 6942804 [No Abstract] [Full Text] [Related]